PRODUCTS
| Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
|---|---|---|---|---|---|---|---|
| Fenofibrate Capsules | 90mg |
 |
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
| Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
 |
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
| Ibuprofen and Famotidine Tablets | 800mg/ 26.6mg |
 |
90 |
70748-312-09 |
Duexis® |
AB |
NSaID |
| Lurasidone Hydrochloride Tablets | 20mg |
|
30 |
68180-670-06 |
Latuda® |
AB |
Atypical antipsychotics |
| Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
|
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
| Moxifloxacin Ophthalmic Solution USP | 0.5% |
|
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
| Nitrofurantoin Macrocrystalline Capsules USP | 50mg |
|
100 |
43386-641-01 |
Macrodantin® |
AB |
Antibiotic |
| Paliperidone Extended-Release Tablet | 1.5mg |
|
30 |
68180-523-06 |
Invega® |
AB |
Atypical antipsychotics |
| Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
|
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
| Rufinamide Tablets USP | 200mg |
|
120 |
68180-803-16 |
Banzel® |
AB |
Anticonvulsants |
| Sevelamer Hydrochloride Tablets | 800mg |
|
180 |
70748-173-26 |
Renagel® |
AB |
Phosphate binders |
| Sildenafil for Oral Suspension | 10mg/mL |
 |
112mL |
68180-283-01 |
Revatio® |
AB |
Phosphodiesterase-5 (PDE-5) Inhibitors |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.
